95 related articles for article (PubMed ID: 17588329)
1. Cysteinyl leukotriene receptor 1 partially mediates brain cryoinjury in mice.
Ding Q; Fang SH; Zhou Y; Zhang LH; Zhang WP; Chen Z; Wei EQ
Acta Pharmacol Sin; 2007 Jul; 28(7):945-52. PubMed ID: 17588329
[TBL] [Abstract][Full Text] [Related]
2. Pranlukast, a cysteinyl leukotriene receptor 1 antagonist, protects mice against brain cold injury.
Qian XD; Wei EQ; Zhang L; Sheng WW; Wang ML; Zhang WP; Chen Z
Eur J Pharmacol; 2006 Nov; 549(1-3):35-40. PubMed ID: 16973153
[TBL] [Abstract][Full Text] [Related]
3. Cysteinyl leukotriene receptor 1 is involved in N-methyl-D-aspartate-mediated neuronal injury in mice.
Ding Q; Wei EQ; Zhang YJ; Zhang WP; Chen Z
Acta Pharmacol Sin; 2006 Dec; 27(12):1526-36. PubMed ID: 17112405
[TBL] [Abstract][Full Text] [Related]
4. Montelukast, a cysteinyl leukotriene receptor-1 antagonist, dose- and time-dependently protects against focal cerebral ischemia in mice.
Yu GL; Wei EQ; Zhang SH; Xu HM; Chu LS; Zhang WP; Zhang Q; Chen Z; Mei RH; Zhao MH
Pharmacology; 2005 Jan; 73(1):31-40. PubMed ID: 15452361
[TBL] [Abstract][Full Text] [Related]
5. Cysteinyl leukotriene receptors CysLT1 and CysLT2 are upregulated in acute neuronal injury after focal cerebral ischemia in mice.
Zhang YJ; Zhang L; Ye YL; Fang SH; Zhou Y; Zhang WP; Lu YB; Wei EQ
Acta Pharmacol Sin; 2006 Dec; 27(12):1553-60. PubMed ID: 17112408
[TBL] [Abstract][Full Text] [Related]
6. Functional expression of cysteinyl leukotriene receptors on human platelets.
Hasegawa S; Ichiyama T; Hashimoto K; Suzuki Y; Hirano R; Fukano R; Furukawa S
Platelets; 2010; 21(4):253-9. PubMed ID: 20433311
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of cysteinyl leukotriene receptor-1 in the brain mediates neuronal damage and astrogliosis after focal cerebral ischemia in rats.
Fang SH; Wei EQ; Zhou Y; Wang ML; Zhang WP; Yu GL; Chu LS; Chen Z
Neuroscience; 2006 Jul; 140(3):969-79. PubMed ID: 16650938
[TBL] [Abstract][Full Text] [Related]
8. Pranlukast inhibits renal epithelial cyst progression via activation of AMP-activated protein kinase.
Pathomthongtaweechai N; Soodvilai S; Chatsudthipong V; Muanprasat C
Eur J Pharmacol; 2014 Feb; 724():67-76. PubMed ID: 24360935
[TBL] [Abstract][Full Text] [Related]
9. Distribution of specific binding sites for cysteinyl leukotriene 1 receptor antagonist in human nasal mucosa.
Shirasaki H; Kanaizumi E; Seki N; Kikuchi M; Watanabe K; Konno N; Himi T
Acta Otolaryngol; 2006 Sep; 126(9):948-51. PubMed ID: 16864492
[TBL] [Abstract][Full Text] [Related]
10. [Cysteinyl leukotriene receptor 1 antagonist pranlukast modulates differentiation of SK-N-SH cells].
Peng F; Fang SH; Zheng XL; Zhang WP; Lu YB; Wei EQ
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2007 Mar; 36(2):123-8. PubMed ID: 17443897
[TBL] [Abstract][Full Text] [Related]
11. ONO-1078 reduces NMDA-induced brain injury and vascular cell adhesion molecule-1 expression in rats.
Zhang LH; Wei EQ
Acta Pharmacol Sin; 2005 Apr; 26(4):435-40. PubMed ID: 15780192
[TBL] [Abstract][Full Text] [Related]
12. Pranlukast reduces neutrophil but not macrophage/microglial accumulation in brain after focal cerebral ischemia in mice.
Chu LS; Wei EQ; Yu GL; Fang SH; Zhou Y; Wang ML; Zhang WP
Acta Pharmacol Sin; 2006 Mar; 27(3):282-8. PubMed ID: 16490162
[TBL] [Abstract][Full Text] [Related]
13. Role for cysteinyl leukotrienes in allergen-induced change in circulating dendritic cell number in asthma.
Parameswaran K; Liang H; Fanat A; Watson R; Snider DP; O'Byrne PM
J Allergy Clin Immunol; 2004 Jul; 114(1):73-9. PubMed ID: 15241347
[TBL] [Abstract][Full Text] [Related]
14. Effects of the cysteinyl leukotriene receptor antagonists pranlukast and zafirlukast on tracheal mucus secretion in ovalbumin-sensitized guinea-pigs in vitro.
Liu YC; Khawaja AM; Rogers DF
Br J Pharmacol; 1998 Jun; 124(3):563-71. PubMed ID: 9647482
[TBL] [Abstract][Full Text] [Related]
15. Functional characterisation of receptors for cysteinyl leukotrienes in smooth muscle.
Jonsson EW
Acta Physiol Scand Suppl; 1998 Mar; 641():1-55. PubMed ID: 9597121
[TBL] [Abstract][Full Text] [Related]
16. Effect of the cysteinyl leukotriene antagonist pranlukast on transendothelial migration of eosinophils.
Nagata M; Saito K; Kikuchi I; Hagiwara K; Kanazawa M
Int Arch Allergy Immunol; 2005; 137 Suppl 1():2-6. PubMed ID: 15947477
[TBL] [Abstract][Full Text] [Related]
17. CysLT1 receptor antagonists pranlukast and zafirlukast inhibit LRRC8-mediated volume regulated anion channels independently of the receptor.
Figueroa EE; Kramer M; Strange K; Denton JS
Am J Physiol Cell Physiol; 2019 Oct; 317(4):C857-C866. PubMed ID: 31390227
[TBL] [Abstract][Full Text] [Related]
18. Intracerebroventricular injection of HAMI 3379, a selective cysteinyl leukotriene receptor 2 antagonist, protects against acute brain injury after focal cerebral ischemia in rats.
Shi QJ; Xiao L; Zhao B; Zhang XY; Wang XR; Xu DM; Yu SY; Fang SH; Lu YB; Zhang WP; Sa XY; Wei EQ
Brain Res; 2012 Nov; 1484():57-67. PubMed ID: 23000196
[TBL] [Abstract][Full Text] [Related]
19. Pranlukast, a leukotriene receptor antagonist, inhibits interleukin-5 production via a mechanism distinct from leukotriene receptor antagonism.
Fukushima C; Matsuse H; Hishikawa Y; Kondo Y; Machida I; Saeki S; Kawano T; Tomari S; Obase Y; Shimoda T; Koji T; Kohno S
Int Arch Allergy Immunol; 2005 Feb; 136(2):165-72. PubMed ID: 15650315
[TBL] [Abstract][Full Text] [Related]
20. Cysteinyl leukotrienes enhance tumour necrosis factor-alpha-induced matrix metalloproteinase-9 in human monocytes/macrophages.
Ichiyama T; Kajimoto M; Hasegawa M; Hashimoto K; Matsubara T; Furukawa S
Clin Exp Allergy; 2007 Apr; 37(4):608-14. PubMed ID: 17430359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
